Fisiología
Saila
Institute Catalá Oncología
Barcelona, EspañaInstitute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2016
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433